tiprankstipranks
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
ACRS
Aclaris Therapeutics
RESEARCH TOOLSreports
Want to see ACRS full AI Analyst Report?

Aclaris Therapeutics (ACRS) Revenue

920 Followers
StatisticsMarket CapRevenue

Aclaris Therapeutics Revenue

Aclaris Therapeutics had a revenue of 2.00M in the quarter ending Mar 31, 2026, with 54.13%. This bring the company's revenue in the last twelve months to 8.37M, Decreased 6.91%. In the fiscal year ending Dec 31, 2025, Aclaris Therapeutics had annual revenue of 7.83M with -58.19% growth.
Revenue (ttm)
8.37M
Revenue Growth
-52.94%
P/S Ratio
80.84
Revenue/Employee
$128,295
Employees
61
Market Cap
$632.68M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
7.83M-10.89M-58.19%
Dec 31, 2024
18.72M-12.53M-40.09%
Dec 31, 2023
31.25M1.50M+5.03%
Dec 31, 2022
29.75M22.99M+340.05%
Dec 31, 2021
6.76M279.00K+4.30%
Dec 31, 2020
6.48M2.25M+53.35%
Dec 31, 2019
4.23M-5.86M-58.11%
Dec 31, 2018
10.09M8.41M+499.58%
Dec 31, 2017
1.68M――